Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About EHC Interactive Breakdown Better Bets vs. EHC Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Encompass Health (EHC)

Market Price (10/31/2025): $118.0 | Market Cap: $11.9 Bil
Sector: Health Care | Industry: Health Care Facilities

Encompass Health (EHC)

Market Price (10/31/2025): $118.0
Market Cap: $11.9 Bil
Sector: Health Care
Industry: Health Care Facilities

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.0%		  
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 19%		  
2 Low stock price volatility
Vol 12M is 27%		  
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 5.0%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 19%
2 Low stock price volatility
Vol 12M is 27%

Market Valuation & Key Metrics

EHCS&P 500
REVENUE GROWTHGOOD
Rev LTM ($ Bil)5.7
Rev Chg Q12.0%6.4%
Rev Chg LTM11.8%5.4%
Rev Chg 3Y Avg10.7%5.3%
PROFITABILITYFAIR
Op Inc LTM ($ Bil)1.0
CFO LTM ($ Bil)1.1
Net Inc LTM ($ Bil)0.5
Op Mgn LTM17.1%18.7%
CFO/Rev LTM19.5%20.4%
Net Inc Mgn9.2%12.8%
VALUATIONMODERATE
P/S2.13.2
P/CFO10.715.5
P/FCF27.020.6
P/E22.723.6
STABILITYGOOD
Debt/Equity0.230.21
Cash/Assets0.010.07

EHC Stock

   
   
   
   
   
   
   
Factor Drivers of Stock Movement
The 1.0% change in EHC stock from 5/1/2025 to 10/30/2025 was primarily driven by a 2.8% change in the company's Total Revenues ($ Mil).

501202510302025Change
Stock Price ($)115.61116.811.04%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)5512.605669.102.84%
Net Income Margin (%)8.97%9.22%2.74%
P/E Multiple23.4922.48-4.28%
Shares Outstanding (Mil)100.50100.60-0.10%
Cumulative Contribution1.04%

LTM = Last Twelve Months as of date shown
The 16.0% change in EHC stock from 10/30/2024 to 10/30/2025 was primarily driven by a 17.0% change in the company's Net Income Margin (%).

1030202410302025Change
Stock Price ($)100.69116.8116.01%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)5070.905669.1011.80%
Net Income Margin (%)7.88%9.22%17.03%
P/E Multiple25.1822.48-10.72%
Shares Outstanding (Mil)99.90100.60-0.70%
Cumulative Contribution16.00%

LTM = Last Twelve Months as of date shown
The 119.8% change in EHC stock from 10/31/2022 to 10/30/2025 was primarily driven by a 39.8% change in the company's P/E Multiple.

1031202210302025Change
Stock Price ($)53.16116.81119.75%
Change Contribution ByLTMLTM
Total Revenues ($ Mil)4175.105669.1035.78%
Net Income Margin (%)7.85%9.22%17.43%
P/E Multiple16.0922.4839.76%
Shares Outstanding (Mil)99.20100.60-1.41%
Cumulative Contribution119.71%

LTM = Last Twelve Months as of date shown

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
EHC Return21%-20%17%13%39%27%145%
Peers Return8%22%-4%2%18%15%75%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
EHC Win Rate58%50%50%50%83%89% 
Peers Win Rate43%50%42%37%47%51% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
EHC Max Drawdown-28%-31%-17%-14%0%-1% 
Peers Max Drawdown-38%-6%-24%-12%-2%-10% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: HCA, DGX, UHS, SEM, BMGL. See EHC Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

Unique KeyEventEHCS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-39.1%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven64.2%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven408 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-39.5%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven65.4%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven246 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-29.9%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven42.7%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven302 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-73.6%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven278.4%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven762 days1480 days

Compare to HCA, DGX, UHS, SEM, BMGL


In The Past

Encompass Health's stock fell -39.1% during the 2022 Inflation Shock from a high on 4/23/2021. A -39.1% loss requires a 64.2% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Encompass Health (EHC)

Better Bets than Encompass Health (EHC)

 EHCBetter Performance than EHC
MetricValueIndustry (Health Care Facilities)
Rev Chg LTM11.8%ENSG (16.3%), OPCH (17.0%), SGRY (12.0%), LFST (13.9%), NHC (23.8%)
Rev Chg 3Y Avg10.7%ENSG (18.0%), OPCH (13.0%), SGRY (10.8%), LFST (19.3%), NHC (11.1%)
Op Mgn LTM17.1%NUTX (33.4%), BTMD (17.8%)
CFO/Rev LTM19.5%JYNT (25.6%), DCGO (20.0%), BTMD (20.8%), CCEL (20.0%)
FCF/Rev LTM7.7%HCA (10.0%), LFST (9.1%), NHC (8.2%), USPH (8.3%), NUTX (11.1%)
Total Yield5.0%HCA (6.0%), THC (7.4%), UHS (9.3%), ARDT (12.5%), ACHC (7.1%)
 EHCBetter Performance than EHC
MetricValueAll Other Sectors
Rev Chg LTM11.8%NVDA (71.6%), MSFT (15.6%), GOOGL (13.4%), AVGO (28.0%), META (21.3%)
Rev Chg 3Y Avg10.7%NVDA (92.0%), MSFT (13.2%), GOOGL (11.0%), AMZN (11.3%), AVGO (24.0%)
Op Mgn LTM17.1%NVDA (58.1%), AAPL (31.9%), MSFT (46.3%), GOOGL (32.2%), AVGO (39.0%)
CFO/Rev LTM19.5%NVDA (46.6%), AAPL (26.6%), MSFT (50.0%), GOOGL (39.3%), AVGO (42.4%)
FCF/Rev LTM7.7%NVDA (43.6%), AAPL (23.5%), MSFT (26.6%), GOOGL (19.1%), AVGO (41.6%)
Total Yield5.0%JPM (6.6%), XOM (9.7%), BAC (6.8%), BABA (36.3%), HD (6.3%)
 Best Bets In Health Care Sector
 EHCRPRX HALO CPRX BMY LNTH PBH BIIB PFE EW ILMN
What You Pay           
P/E22.515.314.112.315.414.014.013.612.811.812.4
P/EBIT11.98.111.010.59.39.69.010.110.329.210.3
What You Get           
Rev Chg Q12.0%7.7%40.8%19.4%2.8%-4.1%-6.6%2.8%10.3%11.9%-4.8%
Rev Chg LTM11.8%3.0%35.0%28.5%1.3%5.7%0.6%4.8%13.5%9.1%-3.3%
Rev Chg 3Y Avg10.7%0.8%35.5%49.9%1.0%34.3%0.8%-0.9%-12.4%3.0%-3.0%
FCF/Rev 3Y Avg4.7%113.4%43.4%38.9%29.0%26.1%21.6%17.0%13.8%11.9%9.0%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 11%, alpha of 1.9%, and sharpe of 0.52

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Encompass Health Earnings Notes  
2How Low Can Encompass Health Stock Really Go?Return 
3Encompass Health vs Apollo Asset Management: Which Is A Better Investment?Counter-Intuitive Comparisons 
4Encompass Health vs United Therapeutics: Which Is A Better Investment?Counter-Intuitive Comparisons 
5null  
6Better Bet Than EHC Stock: Pay Less Than Encompass Health To Get More From OKE, FTI   
7Better Bet Than EHC Stock: Pay Less Than Encompass Health To Get More From UTHR, PTCT   
8EHC Dip Buy Analysis  
9Day 7 of Gains Streak for Encompass Health Stock with 4.6% Return (vs. 32% YTD) [5/20/2025]Notification 
10Encompass Health Total Shareholder Return (TSR): 39.7% in 2024 and 23.3% 3-yr compounded annual returns (above peer average)  
11ARTICLES  
12Mid Cap Stocks Trading At 52-Week High October 1st, 2025
13Market Movers | Winners: MP, SSII, UUUU | Losers: SLP, NATL, EHC July 16th, 2025
14Consider Buying Encompass Health Stock For 20% Upside October 16th, 2020
Title
0DASHBOARDS
1Mid Cap Stocks Trading At 52-Week High
2Market Movers | Winners: MP, SSII, UUUU | Losers: SLP, NATL, EHC
3Consider Buying Encompass Health Stock For 20% Upside
4ARTICLES
5Encompass Health Earnings Notes
6How Low Can Encompass Health Stock Really Go?
7Encompass Health vs Apollo Asset Management: Which Is A Better Investment?
8Encompass Health vs United Therapeutics: Which Is A Better Investment?
9null
10Better Bet Than EHC Stock: Pay Less Than Encompass Health To Get More From OKE, FTI 
11Better Bet Than EHC Stock: Pay Less Than Encompass Health To Get More From UTHR, PTCT 
12EHC Dip Buy Analysis
13Day 7 of Gains Streak for Encompass Health Stock with 4.6% Return (vs. 32% YTD) [5/20/2025]
14Encompass Health Total Shareholder Return (TSR): 39.7% in 2024 and 23.3% 3-yr compounded annual returns (above peer average)

Trade Ideas

Select past ideas related to EHC. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy09302025ADMAADMA BiologicsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-4.6%
REGN_9302025_Dip_Buyer_ValueBuy09302025REGNRegeneron PharmaceuticalsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		16.1%16.1%-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG09262025HAEHaemoneticsDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap		2.6%2.6%-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025WATWatersMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		14.2%14.2%-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper09052025ISRGIntuitive SurgicalMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		15.2%15.2%-8.0%
EHC_6302022_Dip_Buyer_ValueBuy06302022EHCEncompass HealthDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		35.2%54.3%0.0%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy09302025ADMAADMA BiologicsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		5.9%5.9%-4.6%
REGN_9302025_Dip_Buyer_ValueBuy09302025REGNRegeneron PharmaceuticalsDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		16.1%16.1%-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG09262025HAEHaemoneticsDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap		2.6%2.6%-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper09192025WATWatersMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		14.2%14.2%-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper09052025ISRGIntuitive SurgicalMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		15.2%15.2%-8.0%
EHC_6302022_Dip_Buyer_ValueBuy06302022EHCEncompass HealthDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		35.2%54.3%0.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Encompass Health

Financials

EHCHCADGXUHSSEMBMGLMedian
NameEncompas.HCA Heal.Quest Di.Universa.Select M.Basel Me. 
Mkt Price116.81466.80175.75218.6914.201.57146.28
Mkt Cap11.8111.619.714.11.8-14.1
Rev LTM5,66972,69810,85016,4604,331-10,850
Op Inc LTM96811,0781,5311,812116-1,531
FCF LTM4397,2921,393902182-902
FCF 3Y Avg2505,7041,004748216-748
CFO LTM1,10511,9351,8851,900413-1,885
CFO 3Y Avg88510,4511,4541,587438-1,454

Growth & Margins

EHCHCADGXUHSSEMBMGLMedian
NameEncompas.HCA Heal.Quest Di.Universa.Select M.Basel Me. 
Rev Chg LTM11.8%6.4%13.7%9.6%5.9%-9.6%
Rev Chg 3Y Avg10.7%6.6%2.2%8.1%-10.8%-6.6%
Rev Chg Q12.0%6.4%13.2%9.6%4.5%-9.6%
QoQ Delta Rev Chg LTM2.8%1.6%3.1%2.3%1.4%-2.3%
Op Mgn LTM17.1%15.2%14.1%11.0%2.7%-14.1%
Op Mgn 3Y Avg15.9%15.0%13.1%9.5%3.7%-13.1%
QoQ Delta Op Mgn LTM0.3%0.1%0.1%0.1%0.3%-0.1%
CFO/Rev LTM19.5%16.4%17.4%11.5%9.5%-16.4%
CFO/Rev 3Y Avg17.2%15.4%14.5%10.4%10.1%-14.5%
FCF/Rev LTM7.7%10.0%12.8%5.5%4.2%-7.7%
FCF/Rev 3Y Avg4.7%8.4%10.0%4.9%5.0%-5.0%

Valuation

EHCHCADGXUHSSEMBMGLMedian
NameEncompas.HCA Heal.Quest Di.Universa.Select M.Basel Me. 
Mkt Cap11.8111.619.714.11.8-14.1
P/S2.11.51.80.90.4-1.5
P/EBIT11.910.212.57.710.9-10.9
P/E22.518.720.311.212.8-18.7
P/CFO10.69.410.47.44.2-9.4
Total Yield5.0%6.0%6.7%9.3%10.6%-6.7%
Dividend Yield0.6%0.6%1.8%0.4%2.8%-0.6%
FCF Yield 3Y Avg2.5%6.6%5.6%6.4%7.0%-6.4%
D/E0.20.40.30.41.6-0.4
Net D/E0.20.40.30.31.6-0.3

Returns

EHCHCADGXUHSSEMBMGLMedian
NameEncompas.HCA Heal.Quest Di.Universa.Select M.Basel Me. 
1M Rtn-8.0%9.5%-7.4%7.0%10.6%-13.7%-0.2%
3M Rtn6.2%32.1%5.4%31.5%-3.5%-28.3%5.8%
6M Rtn1.0%36.6%0.0%25.5%-21.4%-61.4%0.5%
12M Rtn16.0%30.4%14.8%5.8%-20.1%-14.8%
3Y Rtn119.8%120.1%30.0%91.6%6.0%-91.6%
1M Excs Rtn-7.8%7.9%-4.7%5.8%8.3%-10.6%0.6%
3M Excs Rtn-1.6%21.6%-6.0%25.0%4.2%-31.6%1.3%
6M Excs Rtn-20.7%14.8%-21.7%3.8%-43.2%-83.2%-21.2%
12M Excs Rtn9.1%14.8%-2.3%-9.8%-35.5%--2.3%
3Y Excs Rtn67.5%46.5%-47.2%52.8%-66.1%-46.5%

Financials

$ Mil | FY: 12/312025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q12022Q42022Q3
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/6/20255/1/20252/28/202511/1/20248/6/20245/2/20242/28/202411/1/20238/4/20235/3/20232/27/202311/2/2022
Key Financials Quarterly            
Total Revenue1,4581,4551,4051,3511,3011,3161,2471,2071,1871,1601,1371,090
Ebitda347350312297293284270248260246252208
Operating Income259267232209216208190179184179180148
Net Income142152121108114112888591888945
EPS1.411.501.201.081.131.120.870.850.910.880.890.45
Key Financials TTM            
Total Revenue TTM5,6695,5135,3735,2155,0714,9574,8014,6924,5744,4504,3494,254
Ebitda TTM1,3061,2521,1871,1441,0951,0621,0251,006966909870830
Operating Income TTM968924864822792761732722691656630602
Net Income TTM523495456422400377352354314271271273
Growth Rates Quarterly            
Total Revenue Growth12.0%10.6%12.7%11.9%9.6%13.4%9.6%10.8%11.7%9.5%9.1%7.8%
EBITDA Growth18.4%23.1%15.8%19.7%12.7%15.2%7.2%19.6%27.8%18.9%19.1%-7.2%
Operating Income Growth20.2%28.7%22.3%16.6%17.2%16.2%5.7%20.9%23.0%17.0%18.9%-11.0%
Net Income Growth24.5%34.7%38.0%26.8%24.8%28.3%-2.0%87.9%87.7%0.2%-2.4%-54.6%
Margins Quarterly            
EBITDA Margin23.8%24.0%22.2%22.0%22.5%21.6%21.6%20.6%21.9%21.2%22.1%19.1%
Operating Income Margin17.8%18.3%16.5%15.5%16.6%15.8%15.2%14.9%15.5%15.4%15.8%13.6%
Net Income Margin9.7%10.4%8.6%8.0%8.8%8.5%7.0%7.1%7.7%7.6%7.9%4.2%
Cash & Debt            
Total Cash99968514815413469100118852260
Total Debt2,6862,7032,7142,8002,9452,9192,9332,9252,9392,9742,9922,951
Net Debt / (Cash)2,5872,6072,6282,6522,7912,7852,8642,8262,8212,8892,9702,891
Cash Flows Quarterly            
FCF from Operations27028927926821723920121520722817270
Cash Flows TTM            
FCF from Operations TTM1,1051,0531,003925872862851822677715706657
Returns to Shareholders Quarterly            
Dividends171817151516151515161528
Share Repurchases25328717-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly            
ROIC25.5%27.3%22.8%20.1%19.8%18.8%16.5%16.2%13.4%15.8%15.6%13.4%
Return on Invested Capital (ROIC) TTM            
ROIC TTM24.5%23.2%20.8%19.4%18.0%17.2%16.1%16.2%12.6%14.4%13.5%13.3%

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Inpatient4,6944,2523,918  
Outpatient and other1079797  
Home Health and Hospice   1,0781,092
Inpatient Rehabilitation   3,5663,513
Total4,8014,3494,0154,6444,605


Price Behavior

EHC Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta0.180.270.520.510.530.55
Up Beta2.670.560.760.500.510.60
Down Beta-2.380.310.180.440.440.46
Up Capture51%72%52%67%61%36%
Bmk +ve Days13233574144420
Stock +ve Days11233476137405
Down Capture-52%-69%58%53%62%69%
Bmk -ve Days8192952107330
Stock -ve Days10193050114343

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity1,656,513
Short Interest: % Change Since 9302025-4.9%
Average Daily Volume644,114
Days-to-Cover Short Interest2.57
Basic Shares Quantity100,600,000
Short % of Basic Shares1.6%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
10/29/2025-7.0%  
8/4/20254.0%7.3%12.9%
4/24/202511.8%14.3%17.2%
2/6/20251.3%1.6%0.5%
10/28/20247.4%7.7%11.5%
8/5/2024-5.6%-3.1%4.4%
4/24/2024-0.1%0.1%2.1%
2/7/20240.9%0.8%5.1%
...
SUMMARY STATS   
# Positive151814
# Negative9610
Median Positive2.7%3.4%9.0%
Median Negative-0.8%-3.1%-6.2%
Max Positive11.8%14.3%28.3%
Max Negative-7.0%-5.4%-12.4%

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value		Value of
Held Shares		Form
0Tuer Patrick WilliamEVP, Chief Operating Officer8272025Sell123.591,020126,0622,329,177Form
1Charbonneau Elissa JoyChief Medical Officer5072025Sell116.614,279498,9741,394,429Form
2Price Andrew LChief Accounting Officer2132025Sell98.295,042495,5786,798,130Form

Industry Resources

External Quote Links


Prefer one of these to Trefis? Tell us why.